Checkpoint Immunotherapy for Melanoma and Advanced Cancer: Current and Novel Targets


Dr. Jason Luke, assistant professor of medicine, explains the basic aspects as well as biomarkers of an effective antitumor immune response and reviews data from completed immunotherapy trials for melanoma and advanced cancers.  Dr. Luke also outlines novel drug targets and rational combination immunotherapy strategies



Jason Luke

Jason Luke

Assistant Professor of Medicine

Admissions, Referrals and Consultations:

Call UCM Physician Connect at
Contact Us